EDWARD LEVINE: Open Payments
NPI 1689761926 · STATEN ISLAND, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$715 in 28 payments from 8 companies in 2025. Trend: 2023 $665 · 2024 $828 · 2025 $715
Food & beverage: $715
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $209 |
| Eisai Inc. | 3 | $185 |
| Exact Sciences Corporation | 4 | $116 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $108 |
| Lilly USA, LLC | 2 | $37 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| KYOWA KIRIN, INC. | 1 | $22 |
| Novo Nordisk Inc | 1 | $16 |
Products named: Leqembi, FASENRA, JARDIANCE, The Cologuard Plus Collection Kit, BREZTRI, Cologuard Collection Kit, GVOKE HYPOPEN, AIRSUPRA.
Industry payments across NY — which companies pay providers there.
